IL-23R deletion reduces Th17 cells and ameliorates autoimmune diseases in Act1−/− mice, implicating the importance of hyper Th17 cells (with increased STAT3 activation and IL-21 expression) for the autoimmune diseases associated with Act1 deficiency. Here, TRAF3IP2 is linked to autoimmune disease.